2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
- PMID: 38169072
- DOI: 10.1002/ejhf.3024
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
Abstract
Document Reviewers: Rudolf A. de Boer (CPG Review Co-ordinator) (Netherlands), P. Christian Schulze (CPG Review Co-ordinator) (Germany), Elena Arbelo (Spain), Jozef Bartunek (Belgium), Johann Bauersachs (Germany), Michael A. Borger (Germany), Sergio Buccheri (Sweden), Elisabetta Cerbai (Italy), Erwan Donal (France), Frank Edelmann (Germany), Gloria Färber (Germany), Bettina Heidecker (Germany), Borja Ibanez (Spain), Stefan James (Sweden), Lars Køber (Denmark), Konstantinos C. Koskinas (Switzerland), Josep Masip (Spain), John William McEvoy (Ireland), Robert Mentz (United States of America), Borislava Mihaylova (United Kingdom), Jacob Eifer Møller (Denmark), Wilfried Mullens (Belgium), Lis Neubeck (United Kingdom), Jens Cosedis Nielsen (Denmark), Agnes A. Pasquet (Belgium), Piotr Ponikowski (Poland), Eva Prescott (Denmark), Amina Rakisheva (Kazakhstan), Bianca Rocca (Italy), Xavier Rossello (Spain), Leyla Elif Sade (United States of America/Türkiye), Hannah Schaubroeck (Belgium), Elena Tessitore (Switzerland), Mariya Tokmakova (Bulgaria), Peter van der Meer (Netherlands), Isabelle C. Van Gelder (Netherlands), Mattias Van Heetvelde (Belgium), Christiaan Vrints (Belgium), Matthias Wilhelm (Switzerland), Adam Witkowski (Poland), and Katja Zeppenfeld (Netherlands) All experts involved in the development of this Focused Update have submitted declarations of interest. These have been compiled in a report and simultaneously published in a supplementary document to the Focused Update. The report is also available on the ESC website www.escardio.org/guidelines See the European Heart Journal online for supplementary documents that include evidence tables.
Keywords: Acute heart failure; Chronic kidney disease hospitalization; Comorbidities; Diagnosis; Ejection fraction; Guidelines; Heart failure; Multidisciplinary management; Natriuretic peptides; Neurohormonal antagonists; Pharmacotherapy; Prevention.
© 2024 European Society of Cardiology.
Similar articles
-
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.Eur J Heart Fail. 2022 Jan;24(1):4-131. doi: 10.1002/ejhf.2333. Eur J Heart Fail. 2022. PMID: 35083827
-
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940. J Hypertens. 2018. PMID: 30234752
-
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20. Eur J Heart Fail. 2016. PMID: 27207191 No abstract available.
-
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur J Heart Fail. 2008 Oct;10(10):933-89. doi: 10.1016/j.ejheart.2008.08.005. Epub 2008 Sep 16. Eur J Heart Fail. 2008. PMID: 18826876 Review. No abstract available.
-
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur Heart J. 2008 Oct;29(19):2388-442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17. Eur Heart J. 2008. PMID: 18799522 Review. No abstract available.
Cited by
-
Therapeutic strategies for primary heart involvement in systemic sclerosis.Rheumatol Immunol Res. 2024 Jul 15;5(2):72-82. doi: 10.1515/rir-2024-0010. eCollection 2024 Jun. Rheumatol Immunol Res. 2024. PMID: 39015843 Free PMC article.
-
Sedentary behaviour may cause differences in physical outcomes and activities of daily living in older cardiovascular disease patients participating in phase I cardiac rehabilitation.Sci Rep. 2024 Jun 18;14(1):14037. doi: 10.1038/s41598-024-65001-8. Sci Rep. 2024. PMID: 38890441 Free PMC article.
-
Pediatric Chronic Heart Failure: Age-Specific Considerations of Medical Therapy.Physiol Res. 2024 Nov 29;73(S2):S597-S613. doi: 10.33549/physiolres.935438. Physiol Res. 2024. PMID: 39589305 Free PMC article. Review.
-
Diagnosing and managing patients with heart failure with preserved ejection fraction: a consensus survey.BMJ Open. 2024 Dec 20;14(12):e092993. doi: 10.1136/bmjopen-2024-092993. BMJ Open. 2024. PMID: 39806710 Free PMC article.
-
Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry.Eur J Heart Fail. 2025 Mar;27(3):421-431. doi: 10.1002/ejhf.3565. Epub 2025 Jan 9. Eur J Heart Fail. 2025. PMID: 39783801 Free PMC article.
References
-
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-726. https://doi.org/10.1093/eurheartj/ehab368
-
- Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, et al Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 2022;387:1185-95. https://doi.org/10.1056/NEJMoa2203094
-
- Trullàs JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, Sánchez-Marteles M, Conde-Martel A, et al Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J 2023;44:411-21. https://doi.org/10.1093/eurheartj/ehac689
-
- Lee DS, Straus SE, Farkouh ME, Austin PC, Taljaard M, Chong A, et al Trial of an intervention to improve acute heart failure outcomes. N Engl J Med 2023;388:22-32. https://doi.org/10.1056/NEJMoa2211680
-
- Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al Dapagliflozin in patients with chronic kidney disease. N Engl J Med 2020;383:1436-46. https://doi.org/10.1056/NEJMoa2024816
MeSH terms
LinkOut - more resources
Full Text Sources
Medical